Glioma stem cells
Showing 1 - 25 of >10,000
Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection, Dissecting ciliogenesis players, Validating
Recruiting
- Glioblastoma
- Glioma, Malignant
- Biological sample collection
- +2 more
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023
Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection)
Recruiting
- Glioblastoma
- Glioma, Malignant
- Biological sample collection
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023
Mapping of Tumor Stem Cells in Resection Marigin During
Recruiting
- Glioma, Malignant
- GlioStem
-
Stockholm, SwedenKarolinska University Hospital
Sep 22, 2022
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
Recurrent Glioblastoma Trial in Los Angeles (Activated T cells)
Not yet recruiting
- Recurrent Glioblastoma
- Activated T cells
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Apr 21, 2022
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Withdrawn
- Recurrent Anaplastic Astrocytoma
- +7 more
- Neural Stem Cells-expressing CRAd-S-pk7
- Resection
- (no location specified)
Nov 22, 2022
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Active, not recruiting
- Recurrent Anaplastic Astrocytoma
- +6 more
- Carboxylesterase-expressing Allogeneic Neural Stem Cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,
Recruiting
- Malignant Glioma
- High Grade Glioma
- TTRNA-DC vaccines with GM-CSF
- +4 more
-
Birmingham, Alabama
- +2 more
Feb 2, 2023
Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,
Recruiting
- Diffuse Intrinsic Pontine Glioma (DIPG)
- Brain Stem Glioma
- TTRNA-DC vaccines with GM-CSF
- +5 more
-
Gainesville, FloridaUF Health Shands Children's Hospital
Apr 29, 2022
Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard
Completed
- Glioblastoma
- +4 more
- Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
- Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 18, 2021
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)
Active, not recruiting
- Glioblastoma
- +3 more
- Stereotactic Radiosurgery
-
Lake Success, New YorkNorthwell Health Brain Tumor Center
Feb 3, 2022
Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- +5 more
- Re-irradiation
- (no location specified)
Oct 16, 2023
Diffuse Intrinsic Pontine Glioma, Medulloblastoma, Childhood, Recurrent Trial in Madrid (AloCELYVIR)
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Medulloblastoma, Childhood, Recurrent
- AloCELYVIR
-
Madrid, SpainHospital Infantil Universitario Niño Jesús
Sep 29, 2022
Dermal Regeneration Trial in Lahore (Autologous Mesenchymal stem cells injection, Homogenized fat injection)
Recruiting
- Dermal Regeneration
- Autologous Mesenchymal stem cells injection
- Homogenized fat injection
-
Lahore, Punjab, PakistanKing Edward Medical University
Nov 17, 2023
Osteoarthritis, Knee Trial (Human Umbilical Mesenchymal Stem Cells)
Not yet recruiting
- Osteoarthritis, Knee
- Human Umbilical Mesenchymal Stem Cells
- (no location specified)
Oct 8, 2023
Glioma of Spinal Cord, Glioma of Brainstem Trial in Stanford (GD2 CAR T cells, Fludarabine, Cyclophosphamide)
Recruiting
- Glioma of Spinal Cord
- Glioma of Brainstem
- GD2 CAR T cells
- +2 more
-
Stanford, CaliforniaLucile Packard Children's Hospital (LPCH)
Jun 22, 2022
Diffuse Midline Glioma, H3 K27M-Mutant Trial (GD2 CAR T cells)
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- GD2 CAR T cells
- (no location specified)
Sep 15, 2022
Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)
Not yet recruiting
- Decompensated Cirrhosis
- Human Umbilical Cord-derived Mesenchymal Stem Cells
-
Beijing, ChinaBeijing 302 Hospital
Aug 2, 2023
Periodontitis Trial in Beijing (Human Dental Fulp Stem Cells)
Not yet recruiting
- Periodontitis
- Human Dental Fulp Stem Cells
-
Beijing, Beijng, ChinaPeking University Third Hospital
Jun 20, 2023
Preparation of Patient Autologous Induced Pluripotent Stem
Not yet recruiting
- Age-Related Macular Degeneration
- somatic cell collection
- (no location specified)
Aug 14, 2023
AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)
Recruiting
- AIDS Virus
- Disorder of Immune Reconstitution
- normal saline
- Mesenchymal stem cells
-
Jinan, Shandong, ChinaShandong Public Health Clinical Center
May 14, 2023
Heart Failure, Systolic Trial (CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs))
Not yet recruiting
- Heart Failure, Systolic
- CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs)
- (no location specified)
Jun 22, 2023
CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)
Not yet recruiting
- CMV Infection
- +2 more
- Virus specific T cells
- (no location specified)
Oct 4, 2023
Diffuse Midline Glioma, H3 K27M-Mutant Trial in San Francisco (Cyclophosphamide, Fludarabine, Autologous Anti-H3.3K27M
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- Cyclophosphamide
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 15, 2022